These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25826681)

  • 1. Appropriateness of using patient-derived xenograft models for pharmacologic evaluation of novel therapies for esophageal/gastro-esophageal junction cancers.
    Dodbiba L; Teichman J; Fleet A; Thai H; Starmans MH; Navab R; Chen Z; Girgis H; Eng L; Espin-Garcia O; Shen X; Bandarchi B; Schwock J; Tsao MS; El-Zimaity H; Der SD; Xu W; Bristow RG; Darling GE; Boutros PC; Ailles LE; Liu G
    PLoS One; 2015; 10(3):e0121872. PubMed ID: 25826681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary esophageal and gastro-esophageal junction cancer xenograft models: clinicopathological features and engraftment.
    Dodbiba L; Teichman J; Fleet A; Thai H; Sun B; Panchal D; Patel D; Tse A; Chen Z; Faluyi OO; Renouf DJ; Girgis H; Bandarchi B; Schwock J; Xu W; Bristow RG; Tsao MS; Darling GE; Ailles LE; El-Zimaity H; Liu G
    Lab Invest; 2013 Apr; 93(4):397-407. PubMed ID: 23399854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
    Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
    Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer.
    John T; Kohler D; Pintilie M; Yanagawa N; Pham NA; Li M; Panchal D; Hui F; Meng F; Shepherd FA; Tsao MS
    Clin Cancer Res; 2011 Jan; 17(1):134-41. PubMed ID: 21081655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GEAMP, a novel gastroesophageal junction carcinoma cell line derived from a malignant pleural effusion.
    Zhang W; Williams TA; Bhagwath AS; Hiermann JS; Peacock CD; Watkins DN; Ding P; Park JY; Montgomery EA; Forastiere AA; Jie C; Cantarel BL; Pham TH; Wang DH
    Lab Invest; 2020 Jan; 100(1):16-26. PubMed ID: 31292541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase inhibitors decrease the growth and induce regression of human esophageal adenocarcinoma xenografts in nude mice.
    Santander S; Cebrián C; Esquivias P; Conde B; Esteva F; Jiménez P; Ortego J; Lanas A; Piazuelo E
    Int J Oncol; 2012 Feb; 40(2):527-34. PubMed ID: 21971589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinicopathologic features and treatment outcomes of patients with human epidermal growth factor receptor 2-positive adenocarcinoma of the esophagus and gastroesophageal junction.
    Phillips BE; Tubbs RR; Rice TW; Rybicki LA; Plesec T; Rodriguez CP; Videtic GM; Saxton JP; Ives DI; Adelstein DJ
    Dis Esophagus; 2013 Apr; 26(3):299-304. PubMed ID: 22676551
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Xenografts of primary human gynecological tumors grown under the renal capsule of NOD/SCID mice show genetic stability during serial transplantation and respond to cytotoxic chemotherapy.
    Press JZ; Kenyon JA; Xue H; Miller MA; De Luca A; Miller DM; Huntsman DG; Gilks CB; McAlpine JN; Wang YZ
    Gynecol Oncol; 2008 Aug; 110(2):256-64. PubMed ID: 18547621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-resolution array comparative genomic hybridization of chromosome 8q: evaluation of putative progression markers for gastroesophageal junction adenocarcinomas.
    van Duin M; van Marion R; Vissers KJ; Hop WC; Dinjens WN; Tilanus HW; Siersema PD; van Dekken H
    Cytogenet Genome Res; 2007; 118(2-4):130-7. PubMed ID: 18000363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advanced gastric cancer (GC) and cancer of the gastro-oesophageal junction (GEJ): focus on targeted therapies.
    Cappetta A; Lonardi S; Pastorelli D; Bergamo F; Lombardi G; Zagonel V
    Crit Rev Oncol Hematol; 2012 Jan; 81(1):38-48. PubMed ID: 21256046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models.
    Martins-Filho SN; Weiss J; Pham NA; Li Q; Cabanero M; Fares A; Stewart EL; Shi R; Patel D; Pal P; McConnell J; Bradbury PA; Sacher AG; Leighl NB; Grindlay A; Allison F; Li M; Yasufuku K; Shepherd FA; Moghal N; Tsao MS; Liu G
    Lung Cancer; 2020 Jul; 145():144-151. PubMed ID: 32447118
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intramuscular Transplantation Improves Engraftment Rates for Esophageal Patient-Derived Tumor Xenografts.
    Read M; Liu D; Duong CP; Cullinane C; Murray WK; Fennell CM; Shortt J; Westerman D; Burton P; Clemons NJ; Phillips WA
    Ann Surg Oncol; 2016 Jan; 23(1):305-11. PubMed ID: 25691278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of locoregional versus extended locoregional radiation volumes for patients with nonmetastatic gastro-esophageal junction carcinomas.
    Wang J; Milton DR; He L; Komaki R; Liao Z; Crane CH; Minsky BD; Thall PF; Lin SH
    J Thorac Oncol; 2015 Mar; 10(3):518-26. PubMed ID: 25695222
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenocarcinoma of the GEJ: gastric or oesophageal cancer?
    Rüschoff J
    Recent Results Cancer Res; 2012; 196():107-13. PubMed ID: 23129369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter phase II study of irinotecan, cisplatin, and bevacizumab in patients with metastatic gastric or gastroesophageal junction adenocarcinoma.
    Shah MA; Ramanathan RK; Ilson DH; Levnor A; D'Adamo D; O'Reilly E; Tse A; Trocola R; Schwartz L; Capanu M; Schwartz GK; Kelsen DP
    J Clin Oncol; 2006 Nov; 24(33):5201-6. PubMed ID: 17114652
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Animal Model: Xenograft Mouse Models in Esophageal Adenocarcinoma.
    Hassan MS; von Holzen U
    Methods Mol Biol; 2018; 1756():151-164. PubMed ID: 29600368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative genomic hybridization of cancer of the gastroesophageal junction: deletion of 14Q31-32.1 discriminates between esophageal (Barrett's) and gastric cardia adenocarcinomas.
    van Dekken H; Geelen E; Dinjens WN; Wijnhoven BP; Tilanus HW; Tanke HJ; Rosenberg C
    Cancer Res; 1999 Feb; 59(3):748-52. PubMed ID: 9973227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NeoFLOT: Multicenter phase II study of perioperative chemotherapy in resectable adenocarcinoma of the gastroesophageal junction or gastric adenocarcinoma-Very good response predominantly in patients with intestinal type tumors.
    Schulz C; Kullmann F; Kunzmann V; Fuchs M; Geissler M; Vehling-Kaiser U; Stauder H; Wein A; Al-Batran SE; Kubin T; Schäfer C; Stintzing S; Giessen C; Modest DP; Ridwelski K; Heinemann V
    Int J Cancer; 2015 Aug; 137(3):678-85. PubMed ID: 25530271
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety, efficacy, and long-term follow-up evaluation of perioperative epirubicin, Cisplatin, and capecitabine chemotherapy in esophageal resection for adenocarcinoma.
    van der Sluis PC; Ubink I; van der Horst S; Boonstra JJ; Voest EE; Ruurda JP; Borel Rinkes IH; Wiezer MJ; Schipper ME; Siersema PD; Los M; Lolkema MP; van Hillegersberg R
    Ann Surg Oncol; 2015 May; 22(5):1555-63. PubMed ID: 25564156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient-Derived Gastric Carcinoma Xenograft Mouse Models Faithfully Represent Human Tumor Molecular Diversity.
    Zhang T; Zhang L; Fan S; Zhang M; Fu H; Liu Y; Yin X; Chen H; Xie L; Zhang J; Gavine PR; Gu Y; Ni X; Su X
    PLoS One; 2015; 10(7):e0134493. PubMed ID: 26217940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.